FDA considerations for GenAI-enabled medical devices
On 18 August 2026, the FDA’s CDRH published “Considerations for the Regulation of Generative AI-Enabled Medical Devices”, a discussion paper…
Congenius
On 18 August 2026, the FDA’s CDRH published “Considerations for the Regulation of Generative AI-Enabled Medical Devices”, a discussion paper…
Congenius
Our Summer 2026 MedTech news roundup covers a new MDCG position paper on UDI assignment between manufacturers and distributors, and…
Congenius
Last month (July 2026), CEN & CENELEC published the European Standard EN 18286, which defines a QMS specifically to meet…
Congenius
The Commission’s proposal COM (2025) 1023 final (widely known as MDR 2.0) aims to simplify and streamline the MDR by…
Congenius
The goal of a CAPA (Corrective and Preventive Action) is to solve a problem or issue. When this goal is…
Congenius
The EU Commission’s proposal COM (2025) 1023 final – widely referred to within the medical device industry as MDR 2.0,…
Congenius